Morl Christopher John

Track

Insider profile

Morl Christopher John's trades of Deciphera Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2020-01-17 2020-01-16
PlS Planned sale
1,242 +30.5%
138.63
US$2,385,930 		1,242 +30.5% 138.63 US$2,385,930
2020-01-17 2020-01-15
PlS Planned sale
71,564 -26.1%
291.80
US$3,192,031 		71,564 -26.1% 291.80 US$3,192,031
2020-01-09 2020-01-08
PlS Planned sale
52,654 +6.2%
406.80
US$1,842,097 		52,654 +6.2% 406.80 US$1,842,097
2020-01-09 2020-01-07
PlS Planned sale
1,650 -100.0%
60.02
US$99,035 		1,650 -100.0% 60.02 US$99,035
2020-01-06 2020-01-02
PlS Planned sale
400 -100.0%
62.25
US$24,900 		400 -100.0% 62.25 US$24,900
2020-01-06 2020-01-02
PlS Planned sale
800 -66.7%
61.58
US$49,266 		800 -66.7% 61.58 US$49,266
2020-01-06 2020-01-02
PlS Planned sale
800 -40.0%
60.58
US$48,463 		800 -40.0% 60.58 US$48,463
2020-01-06 2020-01-02
PlS Planned sale
2,103 -51.3%
59.48
US$125,087 		2,103 -51.3% 59.48 US$125,087
2020-01-06 2020-01-02
PlS Planned sale
3,529 -46.2%
58.38
US$206,039 		3,529 -46.2% 58.38 US$206,039
2020-01-06 2020-01-02
PlS Planned sale
8,505 -52.7%
57.74
US$491,117 		8,505 -52.7% 57.74 US$491,117